Navigation Links
Arete Therapeutics Appoints Donald Santel to Board of Directors
Date:12/6/2007

HAYWARD, Calif., Dec. 6 /PRNewswire/ -- Arete Therapeutics Inc., a privately-held biopharmaceutical company developing first-in-class small molecule therapeutics for the treatment of cardiovascular, inflammatory and metabolic diseases, today announced the appointment of Donald J. Santel to its board of directors.

"We are very pleased to welcome Don to our board of directors, as his strategic and operational insights will be of great benefit to the Company as we advance our first-in-class antihypertensive agent AR9281 toward a clinical proof of concept," said Dinesh V. Patel, Ph.D., president and chief executive officer of Arete Therapeutics.

"Don's broad experience coupled with his understanding of the opportunities and challenges in building innovative healthcare organizations make him a valuable addition to the board of directors," said James Topper, M.D., Ph.D., chairman of the board of Arete Therapeutics.

Donald J. Santel brings more than 25 years experience in the biotechnology/biopharmaceutical and medical device industries. Most recently, he was co-founder and chief executive officer at CoTherix, Inc., where he launched Ventavis(R) Inhalation Solution and led the sale of the company to Actelion Pharmaceuticals, Ltd. in January 2007. Prior to CoTherix, he served as president and chief operating officer of Reflow, and sold the company to Fox Hollow (now EV3) and served as vice president of marketing and international sales at Cardiac Pathways Corporation, a medical device company later acquired by Boston Scientific. Mr. Santel began his career at Medtronic, Inc. Currently, Mr. Santel also serves on the board of Anthera Pharmaceuticals, ChemGenex Pharmaceuticals, and Hyperion Therapeutics. He has a BSE from Purdue University and an MS in from the University of Minnesota.

About Arete Therapeutics Inc.

Arete Therapeutics Inc. is a privately held pharmaceutical Company discovering and developing first-in-class small molecul
'/>"/>

SOURCE Arete Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CareTech Solutions Executive to Conduct Presentation on Creating a Healthy Revenue Cycle at AHIMA Convention and Exhibit
2. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
3. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
4. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
5. Prime Therapeutics Receives TIPPS Certification
6. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
7. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
8. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
9. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
10. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
11. Prime Therapeutics Announces URAC Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... The benefits of medical imaging far outweigh the risks ... Way, with The Right Radiation Dose. However, overuse and ... Clinic is leading a collaborative effort to ensure a ... online in the Journal of Patient Safety , ... Commission, the Intersociety Accreditation Commission, and the Centers for ...
(Date:7/10/2014)... (July 10, 2014) A research review identifying the ... important first step in the process of developing evidence-based ... a new report published by Neurosurgery ... Neurological Surgeons . The journal is published by ... Wolters Kluwer Health . , Based on ...
(Date:7/10/2014)... localized prostate cancer were more likely to be ... effective treatments and survived for shorter times than ... UCLA study has found. , The negative outcomes ... as bias against the mentally ill, depression,s impact ... of investment in his general health and disinterest ...
(Date:7/10/2014)... new drug could prove useful in treating small cell lung ... Scientists from the Cancer Research UK Manchester Institute, based at ... Research Centre, teamed up with experts at AstraZeneca, as part ... known as AZD3965 - on small cell lung cancer ... Cancer Research , also helps identify which patients are most ...
(Date:7/9/2014)... 10, 2014 -- The World Health Organization recommends that ... moderate to vigorous physical activity (MVPA) each day. ... MVPA during school hours. Therefore, it stands to ... increase MVPA. In a new study scheduled for ... confirmed that time spent outdoors after school was positively ...
Breaking Medicine News(10 mins):Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Go play outside! Outdoor time promotes physical activity in youth 2
... is,a leader in serving people who are visually impaired -- ... People who are legally blind can function and lead effectively ... The news that Lt. Gov. Paterson will become Governor ... people with vision loss can,achieve great heights., As I ...
... the finding shouldn,t keep physicians from using Avastin, researchers say ... cancer drug Avastin can cause kidney damage by doing what ... study shows. , Avastin, whose generic name is bevacizumab, is ... attack cancers by cutting off their blood supply. It does ...
... 12 As previously,disclosed in its Form 8-K filed ... NHWK ) announced that Ernest G. Ludy has resigned,from ... of Directors for,personal reasons. As a result of such ... with Nasdaq Marketplace Rule,4350(d)(2) -- which requires the company,s ...
... Omega T, an Omega 3 and Turmeric ... ... makers,of Conquer HA(TM), introduce the latest addition to their family of joint,relief ... T,is powerful natural anti-inflammatory formula containing Omega 3 and,Turmeric for double strength ...
... 2008) The American Society of Nephrology (ASN), in ... American Society of Pediatric Nephrology (ASPN), will celebrate the ... and patient advocates from across the nation will hold ... raise awareness of chronic kidney disease (CKD) as a ...
... observed that cancer cells perform energy metabolism in a way ... later, this observation was exploited by clinicians to better visualize ... not been known exactly how tumor cells perform this alternate ... essential for tumor growth. , Now, two papers appearing in ...
Cached Medicine News:Health News:Doctors See How Cancer Drug Can Damage Kidneys 2Health News:Doctors See How Cancer Drug Can Damage Kidneys 3Health News:Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market 2Health News:The Makers of Conquer HA(TM) Launch All-Natural Double Strength Anti- Inflammatory Formula 2Health News:ASN members visit Capitol Hill to promote World Kidney Day and CKD awareness 2Health News:Study helps explain fundamental process of tumor growth 2Health News:Study helps explain fundamental process of tumor growth 3
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... May 18, 2011 The Consumer Healthcare Products ... acetaminophen medicines for children, applauds the U.S. Food ... and caregivers give their children the right amount ... Committee and Pediatric Advisory Committee recommended enhancing the ...
... Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of ... neuro-otologic, vestibular and neurological testing, said today that ... control and analysis software. Clinical specialists ... conduct vestibular, oculomotor and optokinetic tests to detect ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
The base of the staple is round and threaded to enable screwing onto the stapler. The base also has spikes. The legs of the staple are contoured to prevent the staple from backing out....
The staple fixation system provides a simple means of attaching tissue to bone....
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
Medicine Products: